Reyon Pharmaceutical Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,293
11,593
11,338
11,792
13,424
1,341
Depreciation, Depletion & Amortization
2,397
1,855
1,760
1,942
2,005
1,867
Other Funds
-
-
-
-
173
656
Funds from Operations
8,932
10,059
5,791
10,928
14,086
24,799
Changes in Working Capital
8,984
5,043
7,098
48
3,366
36,249
Net Operating Cash Flow
52
15,102
12,889
10,880
17,452
11,449
Capital Expenditures
4,351
5,756
4,840
4,622
5,376
Sale of Fixed Assets & Businesses
-
34
6
9
10
Purchase/Sale of Investments
3,336
4,487
9,217
1,792
48,013
Net Investing Cash Flow
9,803
7,331
3,855
8,121
51,536
Cash Dividends Paid - Total
-
-
3,225
3,870
4,515
Issuance/Reduction of Debt, Net
7,724
5,946
12,812
-
37,778
Net Financing Cash Flow
7,724
5,946
16,037
3,870
33,063
Net Change in Cash
2,131
1,825
708
1,112
1,021
Free Cash Flow
1,009
12,898
11,822
8,459
12,816
Deferred Taxes & Investment Tax Credit
212
641
568
-
-
28,664
Other Sources
-
2,942
9
22
1,843
Change in Capital Stock
-
-
-
-
27
Exchange Rate Effect
-
-
1
-
-
Other Uses
2,150
38
540
1,730
-
About Reyon Pharmaceutical Co.
View Profile
